Neudle.com: benign multiple sclerosis

Differential
(Click to cross reference)

acoustic neurinoma

acute disseminated encephalomyelitis

acute necrotizing encephalitis

advances in neurology

adverse drug reaction

alcohol

alemtuzumab

algorithm

altered states of consciousness

Alzheimer's disease

Alzheimer's disease, preclinical

amphetamines

amyloid angiopathy, cerebral

amyloid beta protein

amyloid imaging

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiitis, isolated of CNS, benign focal

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, cerebral, reversible abnormality

Arnold Chiari malformation

benign essential tremor

benign positional vertigo

beta adrenergic blocker

brainstem, infarction of

calcification, intracranial

calcium antagonist

Call-Fleming syndrome

carbon monoxide poisoning

carcinoma

carcinoma of lung

cardiovascular disease

carotid artery occlusion, neck

carotid artery stenosis

case studies

CAT scan

CAT scan, abnormal

CAT scan, demyelinating disease

cataracts, congenital

central nervous system, infection of

central pontine myelinolysis

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral edema

cerebral edema, vasogenic

cerebral infarction, hemorrhagic

cerebral palsy

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, cytology

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, xanthochromia of

cerebrovascular accident

cerebrovascular accident, non atherosclerotic cause of

cerebrovascular accident, women

cerebrovascular accident, young adult

cerebrovascular disease, risk factors in

chemotherapy, CNS treatment and complications with

congenital malformation

conus medullaris, lesion of

conversion reaction

cortical blindness

cranio-cervical junction

cyst, benign intracranial

cyst, cortical parenchyma

cyst, porencephalic

cytomegalic inclusion disease

dementia, early detection

demyelinating disease

depression

depression, psychotic

dermatomyositis

diagnostic criteria

differential diagnosis

dilantin

diplopia

disability rating scale, neurological

disability, neurological

down-beat nystagmus

drowsiness

drug induced neurologic disorders

dysarthria

dysexecutive syndrome

electroencephalogram, abnormalities of

electron microscopy

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalomalacia

encephalomyelitis, postinfectious

epidemiology of neurology

eye movement, disorders of

foramen magnum, meningioma

gadolinium

gamma knife therapy

gaze palsy

gaze palsy, horizontal

gender

glioblastoma multiforme(astrocytoma Gr.III)

glioma

gliomatosis cerebri

groin pain

Guillain Barre syndrome

hallucination, auditory

hallucination, hypnagogic

headache, thunderclap

hearing loss

heavy metal intoxication

hemiparesis

hemiplegia

herniated disc

herniated disc, thoracic

herpes labialis

herpes simplex encephalitis

herpes simplex encephalitis, differential diagnosis of

herpes simplex encephalitis, recurrent

herpes simplex encephalitis, treatment of

herpes simplex myelitis

herpes simplex virus

herpes simplex virus infection, immunosuppressed patient

herpes simplex virus, human nervous system and

herpes simplex virus, localization of

herpes simplex virus, malignancy with

herpes simplex virus, pathogenesis of

herpes simplex virus, pathology of

herpes simplex, neurocutaneous lesions in

human immunodeficiency virus type 1

hydrocephalus

hypertension

hypertensive encephalopathy

iatrogenic neurologic disorders

immunofluorescent exam of CSF cells

immunomodulation

immunosuppression

immunosuppressive agents

inclusion bodies, intranuclear

infectious mononucleosis

infliximab

interferon

interferon inducer

internuclear ophthalmoplegia

internuclear ophthalmoplegia, bilateral

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracranial hypertension, benign

intracranial pressure, increased

intrauterine infection, viral

intrauterine infection, viral of CNS

leukoencephalopathy, differential diagnosis

level of consciousness, decreased

lymphoma involving CNS

lymphoma, primary of CNS

malformation, CNS, congenital

memory, impairment of

meningitis

meningitis, aseptic

mental retardation

mental status, abnormal

microcephaly

micropthalmia

middle cerebral artery, occlusion of

middle cerebral artery, stenosis of

migraine

mild cognitive impairment

mimics

misdiagnosis

mitochondrial disease

monoamines

monoamines, brain

monoclonal antibodies

monoparesis

mortality

movement disorder

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, angiography

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, disappearing lesion on

MRI, false negative

MRI, field strength, high

multiple sclerosis, asymptomatic

multiple sclerosis, benign form of

multiple sclerosis, chronic progressive

multiple sclerosis, diagnosis of

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, misdiagnosis

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, relapsing

multiple sclerosis, treatment of

multiple sclerosis, tumefactive

myxedema, neurologic manifestations of

narcolepsy

natalizumab

nausea and vomiting

neoplasm, intracranial, differential diagnosis of

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuromyelitis optica, IgG

neuroophthalmology

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral, treatment

nystagmus

nystagmus, central

nystagmus, peripheral

ocular bobbing

ocular dysmetria

old age, neurology of

optic atrophy

optic nerve, hypoplasia of

optic neuritis

optic neuritis, bilateral

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

periventricular leukomalacia

personality change

personality disorder

phenylketonuria

Pittsburgh Compound B

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

polyinosinic cytidic acid(poly IC)

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, infarction of

posterior leukoencephalopathy syndrome

postpartum

potassium channel antibodies

precipitating factors

pregnancy, neurologic complications in

premature infant

prognosis

progressive multifocal leucoencephalopathy

propranolol

pseudotumor

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

REM sleep

remote effect of cancer on the nervous system

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

seizure, psychomotor-temporal lobe

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skew deviation

sleep

sleep pathology and physiology

spinal cord, compression of

spinal cord, extramedullary cyst of

steroid therapy, CNS treatment and complications with

stimulation, deep brain

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

subtemporal decompression

symmetric brain lesions

syringomyelia

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

talk

tau protein

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamotomy

thromboangiitis obliterans cerebri

thyrotoxicosis

transplacental virus infections

treatment of neurologic disorder

tremor

tremor, cerebellar

tremor, classification

tremor, differential diagnosis of

tremor, surgical treatment of

tremor, thalamic stimulation for suppression of

tremor, treatment of

trigeminal neuralgia

twins

vaccination, neurologic complications with

vasculitides

vasculopathy

vasoconstrictive drugs

vasospasm

vasospasm, cerebral

vertebral-basilar insufficiency

vertebral-basilar insufficiency, differential diagnosis

vertigo

vertigo, basilar artery insufficiency

vertigo, central

vertigo, migraine causing

vertigo, ocular

vertigo, peripheral

vertigo, post-traumatic

viral infection, CNS

vision loss, sequential

visual loss

visual loss, progressive

visual loss, sudden

water channel antibodies

Whipple's disease

white matter disease

Showing articles 850 to 900 of 4864 << Previous Next >>

Neurologic and Developmental Disability After Extremely Preterm Birth
NEJM 343:378-384,429, Wood,N.S. et al, 2000

Familial Neuromyelitis Optica (Devics Syndrome) with Late Onset in Japan
Neurol 55:318-320, Yamakawa,K.,et al, 2000

Leukoencephalopathy and Raised Brain Lactate from Heroin Vapor Inhalation ("Chasing the Dragon")
Neurol 53:589-1048, Kriegstein,A.R., et al, 1999

Multiple Sclerosis in Children Under 6 Years of Age
Neurol 53:478-484, Ruggieri,M.,et al, 1999

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease
Ann Int Med 131:919-926, Shadick,N.A.,et al, 1999

Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999

General Neurologist and Subspecialist Care for Multiple Sclerosis, Patients' Perceptions
Neurol 53:1190-1197, Vickrey,B.G.,et al, 1999

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Isolated Cranial Nerve Palsies Due to Brainstem Lesions
Muscle & Nerve 22:1168-1176, Thomke,F., 1999

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Suppression of Pendular Nystagmus by Smoking Cannabis in a Patient with Multiple Sclerosis
Neurol 53:2209-2210, Schon,F.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999

Chronic Thalamic Stimulation for the Tremor of Multiple Sclerosis
Neurol 53:625-628, Montgomery,E.B.,et al, 1999

Cavernous Haemangioma Mimicking Multiple Sclerosis
BMJ 318:1604-1605, Cader,M.Z.&Winer,J.B., 1999

Cerebrospinal Fluid Findings in CADASIL
Neurol 53:233, Dichgans,M.,et al, 1999

Chlamydia Pneumoniae Infection of the Central Nervous System in Multiple Sclerosis
Ann Neurol 46:6-14,4, Sriram,S.,et al, 1999

Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999

Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999

Recent Advances, Neurology
BMJ 319:362-366, Larner,A.J.&Farmer,S.F., 1999

A Longitudinal Study of Brain Atrophy in Relapsing Multiple Sclerosis
Neurol 53:139-148, Simon,J.H.,et al, 1999

Association of MS with Thyroid Disorders
Neurol 53:883-885, Karni,A.&Abramsky,O., 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999

Olfactory Dysfunction in Multiple Sclerosis:Relation to Longitudinal Changes in Plaque Numbers in Central Olfactory Structures
Neurol 53:880-882, Doty,R.L.,et al, 1999

Isolated Trochlear Nerve Palsy in Patients with Multiple Sclerosis
Neurol 53:877-879, Jacobson,D.M.,et al, 1999

The Contribution of Magnetic Resonance Imaging to the Diagnosis of Multiple Sclerosis
Neurol 53:448-456, Fazekas,F.,et al, 1999

Optic Neuritis as Onset Manifestations of Multiple Sclerosis
Neurol 53:473-478, Sorensen,T.L.,et al, 1999

Rehabilitation of Persons With Traumatic Brain Injury
JAMA 282:974-983,989, NIH Consensus Development Panel on Rehab with TBI, 1999

Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999

The Clinical Course of Neuromyelitis Optica (Devic's Syndrome)
Neurol 53:1107-1114, Wingerchuk,D.M.,et al, 1999

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999

TI-201 SPECT in Pseudotumoral Multiple Sclerosis
Clin Nucl Med 24:186-188, Obach,V.,et al, 1999

Neuropsychological Status in Multiple Sclerosis after Treatment with Glatiramer
Arch Neurol 56:319-324, Weinstein,A.,et al, 1999

Quantitative MRI in Patients with Clinically Isolated Syndromes Suggestive of Demyelination
Neurol 52:599-606, Sailer,M.,et al, 1999

Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999

Utilization of Unconventional Treatments by Persons with MS:Is It Alternative or Complementary?
Neurol 52:626-629, Schwartz,C.E.,et al, 1999

Magnetization Transfer Imaging of Patients with Definite MS and Negative Conventional MRI
Neurol 52:845-848, Filippi,M.,et al, 1999

Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999

Development of Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Images in Multiple Sclerosis,Relation to Inflammatory Activity
Arch Neurol 56:345-351, van Walderveen,M.A.A.,et al, 1999

Multiple Sclerosis Associated with Uveitis in Two Large Clinic-Based Series
Neurol 52:179-181, Biousse,V.,et al, 1999

Magnetic Resonance Imaging-Based Volumetry Differentiates Idiopathic Parkinson's Syndrome from Multiple System Atrophy and Progressive Supranuclear Palsy
Ann Neurol 45:65-74, Schulz,J.B.,et al, 1999

Interferon-alpha 2a Reduces MRI Disease Activity in Relapsing-Remitting Multiple Sclerosis
Neurol 52:1049-1056, Myhr,K.M.,et al, 1999

Quantitative MRI in CADASIL, Correlation with Disability and Cognitive Performance
Neurol 52:1361-1367, Dichgans,M.,et al, 1999

Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999
NEJM 340:945-953, , 1999

Fibromyalgia Syndrome a Decade Later
Arch Int Med 159:777-785, Goldenberg,D.L., 1999

Burden of Migraine in the United States, Disability and Economic Costs
Arch Int Med 159:813-818, Hu,X.H.,et al, 1999

Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Brain Structure and Neurocognitive and Behavioural Function in Adolescents Who Were Born Very Preterm
Lancet 353:1653-1657, Stewart,A.L.,et al, 1999

Showing articles 850 to 900 of 4864 << Previous Next >>